Cancer Incidence and Mortality among Non-Hispanic Black Individuals, New York City, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 9,831.6 | 439.4 | 435.4-443.4 | 4,699.2 | 515.4 | 508.6-522.3 | 5,132.4 | 394.9 | 390.0-399.9 | 3,134.8 | 141.0 | 138.7-143.2 | 1,399.2 | 167.1 | 163.0-171.2 | 1,735.6 | 127.4 | 124.6-130.1 |
Oral cavity and pharynx | 172.2 | 7.7 | 7.2-8.3 | 104.6 | 11.6 | 10.6-12.7 | 67.6 | 5.2 | 4.6-5.8 | 42.8 | 1.9 | 1.7-2.2 | 27.6 | 3.2 | 2.7-3.8 | 15.2 | 1.1 | 0.9-1.4 |
Esophagus | 71.4 | 3.1 | 2.8-3.5 | 44.0 | 4.9 | 4.2-5.6 | 27.4 | 2.0 | 1.7-2.4 | 46.4 | 2.0 | 1.7-2.3 | 28.8 | 3.3 | 2.7-3.9 | 17.6 | 1.2 | 1.0-1.5 |
Stomach | 227.0 | 10.4 | 9.8-11.1 | 120.8 | 14.4 | 13.2-15.6 | 106.2 | 8.1 | 7.4-8.8 | 105.0 | 4.8 | 4.4-5.3 | 61.2 | 7.4 | 6.6-8.4 | 43.8 | 3.3 | 2.8-3.7 |
Colorectal | 836.2 | 37.9 | 36.8-39.1 | 395.6 | 45.2 | 43.2-47.4 | 440.6 | 33.3 | 31.9-34.7 | 321.8 | 14.6 | 13.9-15.4 | 146.0 | 17.5 | 16.2-18.9 | 175.8 | 12.8 | 12.0-13.8 |
Colon excluding rectum | 619.2 | 28.0 | 27.0-29.0 | 276.4 | 31.7 | 30.0-33.5 | 342.8 | 25.7 | 24.5-27.0 | 264.6 | 12.0 | 11.3-12.7 | 115.2 | 13.8 | 12.7-15.1 | 149.4 | 10.9 | 10.1-11.7 |
Rectum & rectosigmoid | 217.0 | 9.9 | 9.3-10.5 | 119.2 | 13.5 | 12.4-14.7 | 97.8 | 7.6 | 6.9-8.3 | 57.2 | 2.6 | 2.3-3.0 | 30.8 | 3.7 | 3.1-4.3 | 26.4 | 2.0 | 1.6-2.3 |
Liver / intrahepatic bile duct | 225.8 | 9.6 | 9.0-10.2 | 154.2 | 16.4 | 15.2-17.6 | 71.6 | 5.1 | 4.5-5.6 | 151.2 | 6.6 | 6.1-7.0 | 99.8 | 11.0 | 10.1-12.1 | 51.4 | 3.7 | 3.2-4.1 |
Pancreas | 326.8 | 14.5 | 13.8-15.2 | 142.0 | 16.0 | 14.8-17.2 | 184.8 | 13.5 | 12.6-14.4 | 247.0 | 11.0 | 10.3-11.6 | 108.2 | 12.2 | 11.2-13.3 | 138.8 | 10.0 | 9.3-10.8 |
Larynx | 60.6 | 2.6 | 2.3-2.9 | 45.2 | 5.0 | 4.4-5.8 | 15.4 | 1.1 | 0.9-1.4 | 22.4 | 1.0 | 0.8-1.2 | 16.2 | 1.9 | 1.5-2.4 | 6.2 | 0.4 | 0.3-0.6 |
Lung and bronchus | 941.8 | 41.4 | 40.2-42.6 | 455.0 | 51.1 | 49.0-53.4 | 486.8 | 35.2 | 33.8-36.7 | 523.2 | 23.1 | 22.2-24.0 | 268.0 | 30.8 | 29.2-32.6 | 255.2 | 18.3 | 17.3-19.4 |
Melanoma of the skin | 20.0 | 0.9 | 0.8-1.1 | 7.2 | 0.8 | 0.6-1.1 | 12.8 | 1.0 | 0.8-1.3 | 3.6 | 0.2 | 0.1-0.3 | 1.6 | 0.2 | 0.1-0.3 | 2.0 | 0.1 | 0.1-0.3 |
Female breast | 1,584.2 | 125.7 | 122.8-128.5 | 323.6 | 24.4 | 23.2-25.7 | ||||||||||||
Cervix uteri | 123.2 | 10.3 | 9.4-11.1 | 42.4 | 3.3 | 2.9-3.8 | ||||||||||||
Corpus uterus and NOS | 507.0 | 36.4 | 35.0-37.9 | 167.8 | 11.9 | 11.1-12.8 | ||||||||||||
Ovary | 129.8 | 10.1 | 9.3-11.0 | 88.6 | 6.4 | 5.8-7.1 | ||||||||||||
Prostate | 1,920.6 | 199.3 | 195.2-203.5 | 251.0 | 33.2 | 31.3-35.1 | ||||||||||||
Testis | 17.6 | 2.0 | 1.6-2.5 | 1.2 | 0.2 | 0.1-0.4 | ||||||||||||
Urinary bladder (incl. in situ) | 223.4 | 10.1 | 9.5-10.7 | 150.8 | 18.2 | 16.9-19.6 | 72.6 | 5.3 | 4.8-5.9 | 56.0 | 2.6 | 2.3-2.9 | 33.8 | 4.4 | 3.7-5.1 | 22.2 | 1.6 | 1.3-1.9 |
Kidney and renal pelvis | 334.2 | 14.8 | 14.1-15.6 | 201.8 | 21.9 | 20.6-23.4 | 132.4 | 9.9 | 9.1-10.7 | 49.8 | 2.2 | 2.0-2.5 | 31.4 | 3.6 | 3.1-4.3 | 18.4 | 1.3 | 1.1-1.6 |
Brain and other central nervous system | 90.4 | 4.4 | 4.0-4.9 | 48.8 | 5.5 | 4.9-6.3 | 41.6 | 3.6 | 3.1-4.1 | 47.8 | 2.3 | 2.0-2.6 | 26.2 | 3.0 | 2.5-3.5 | 21.6 | 1.7 | 1.4-2.1 |
Thyroid | 198.2 | 9.6 | 8.9-10.2 | 34.2 | 3.8 | 3.3-4.5 | 164.0 | 14.0 | 13.0-15.0 | 11.2 | 0.5 | 0.4-0.7 | 2.8 | 0.3 | 0.2-0.6 | 8.4 | 0.6 | 0.4-0.8 |
Hodgkin lymphoma | 56.4 | 2.9 | 2.5-3.2 | 27.8 | 3.1 | 2.6-3.7 | 28.6 | 2.7 | 2.2-3.1 | 5.0 | 0.3 | 0.2-0.4 | 2.4 | 0.3 | 0.1-0.5 | 2.6 | 0.2 | 0.1-0.4 |
Non-Hodgkin lymphomas | 338.2 | 15.9 | 15.1-16.7 | 169.8 | 19.4 | 18.1-20.8 | 168.4 | 13.5 | 12.6-14.5 | 81.0 | 3.7 | 3.4-4.1 | 42.2 | 4.9 | 4.3-5.6 | 38.8 | 2.9 | 2.5-3.4 |
Myeloma | 317.0 | 14.2 | 13.5-15.0 | 142.4 | 16.2 | 15.0-17.5 | 174.6 | 13.0 | 12.1-13.9 | 95.0 | 4.3 | 3.9-4.7 | 43.4 | 5.1 | 4.5-5.9 | 51.6 | 3.7 | 3.3-4.2 |
Leukemias | 220.0 | 10.5 | 9.8-11.1 | 108.2 | 12.7 | 11.6-13.8 | 111.8 | 9.1 | 8.3-9.9 | 95.2 | 4.4 | 4.0-4.8 | 47.8 | 5.7 | 5.0-6.5 | 47.4 | 3.6 | 3.2-4.1 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.